Live Breaking News & Updates on Elevation Oncology Inc

Stay updated with breaking news from Elevation oncology inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Elevation Oncology, Inc. (NASDAQ:ELEV) Given Consensus Recommendation of "Buy" by Analysts

Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) has been given a consensus recommendation of “Buy” by the six research firms that are covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have covered the stock in the last year […] ....

Darwin Global Management Ltd , Sg Americas Securities , Affinity Asset Advisors , Vanguard Group Inc , Artal Group , Elevation Oncology Inc , Elevation Oncology , Get Free Report , Asset Advisors , Darwin Global Management , Get Free , Elevation Oncology Daily ,

Elevation Oncology (NASDAQ:ELEV) Stock Rating Reaffirmed by Wedbush

Wedbush restated their outperform rating on shares of Elevation Oncology (NASDAQ:ELEV – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $8.00 price objective on the stock. ELEV has been the topic of several other reports. JMP Securities restated a market outperform rating and set a $7.00 target price […] ....

Elevation Oncology Inc , Elevation Oncology Company Profile , Elevation Oncology , Free Report , Get Free Report , Elevation Oncology Daily ,

Comparing Aura Biosciences (NASDAQ:AURA) & Elevation Oncology (NASDAQ:ELEV)

Comparing Aura Biosciences (NASDAQ:AURA) & Elevation Oncology (NASDAQ:ELEV)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Aura Biosciences Inc , Megalith Biopharmaceutical Co Ltd , Elevation Oncology Inc , Oncology Inc , Elevation Oncology , Get Free Report , Aura Biosciences , Given Aura Bioscience , Aura Bioscience , Elevation Oncology Daily ,

Elevation Oncology (NASDAQ:ELEV) Given "Outperform" Rating at Wedbush

Wedbush restated their outperform rating on shares of Elevation Oncology (NASDAQ:ELEV – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. Wedbush currently has a $8.00 price objective on the stock. A number of other analysts have also issued reports on ELEV. HC Wainwright reiterated a buy rating and set […] ....

Elevation Oncology Inc , Elevation Oncology , Free Report , Get Free Report , Elevation Oncology Daily ,

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference

Elevation Oncology to Present at the Citizens JMP Life Sciences Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Josephj Ferra , Hannah Deresiewicz , Life Sciences Conference On , Company Investor Relations , Stern Investor Relations Inc , Elevation Oncology Inc , Prnewswire Elevation Oncology Inc , Chief Executive Officer , Elevation Oncology , Sciences Conference , Investor Relations , Oncology Investor , Managing Director , Stern Investor Relations ,